» Articles » PMID: 29917034

Developments in Toxicogenomics: Understanding and Predicting Compound-induced Toxicity from Gene Expression Data

Overview
Journal Mol Omics
Date 2018 Jun 20
PMID 29917034
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

The toxicogenomics field aims to understand and predict toxicity by using 'omics' data in order to study systems-level responses to compound treatments. In recent years there has been a rapid increase in publicly available toxicological and 'omics' data, particularly gene expression data, and a corresponding development of methods for its analysis. In this review, we summarize recent progress relating to the analysis of RNA-Seq and microarray data, review relevant databases, and highlight recent applications of toxicogenomics data for understanding and predicting compound toxicity. These include the analysis of differentially expressed genes and their enrichment, signature matching, methods based on interaction networks, and the analysis of co-expression networks. In the future, these state-of-the-art methods will likely be combined with new technologies, such as whole human body models, to produce a comprehensive systems-level understanding of toxicity that reduces the necessity of in vivo toxicity assessment in animal models.

Citing Articles

Bridging organ transcriptomics for advancing multiple organ toxicity assessment with a generative AI approach.

Li T, Chen X, Tong W NPJ Digit Med. 2024; 7(1):310.

PMID: 39501092 PMC: 11538515. DOI: 10.1038/s41746-024-01317-z.


Computational Strategies for Assessing Adverse Outcome Pathways: Hepatic Steatosis as a Case Study.

Ortega-Vallbona R, Palomino-Schatzlein M, Tolosa L, Benfenati E, Ecker G, Gozalbes R Int J Mol Sci. 2024; 25(20).

PMID: 39456937 PMC: 11508863. DOI: 10.3390/ijms252011154.


Progress in toxicogenomics to protect human health.

Meier M, Harrill J, Johnson K, Thomas R, Tong W, Rager J Nat Rev Genet. 2024; 26(2):105-122.

PMID: 39223311 DOI: 10.1038/s41576-024-00767-1.


A Network Toxicology Approach for Mechanistic Modelling of Nanomaterial Hazard and Adverse Outcomes.

Del Giudice G, Serra A, Pavel A, Maia M, Saarimaki L, Fratello M Adv Sci (Weinh). 2024; 11(32):e2400389.

PMID: 38923832 PMC: 11348149. DOI: 10.1002/advs.202400389.


Probing Liver Injuries Induced by Thioacetamide in Human In Vitro Pooled Hepatocyte Experiments.

Goel H, Printz R, Pannala V, AbdulHameed M, Wallqvist A Int J Mol Sci. 2024; 25(6).

PMID: 38542239 PMC: 10970511. DOI: 10.3390/ijms25063265.


References
1.
Tawa G, AbdulHameed M, Yu X, Kumar K, Ippolito D, Lewis J . Characterization of chemically induced liver injuries using gene co-expression modules. PLoS One. 2014; 9(9):e107230. PMC: 4165895. DOI: 10.1371/journal.pone.0107230. View

2.
Khatoon Z, Figler B, Zhang H, Cheng F . Introduction to RNA-Seq and its applications to drug discovery and development. Drug Dev Res. 2014; 75(5):324-30. DOI: 10.1002/ddr.21215. View

3.
Sellamuthu R, Umbright C, Li S, Kashon M, Joseph P . Mechanisms of crystalline silica-induced pulmonary toxicity revealed by global gene expression profiling. Inhal Toxicol. 2011; 23(14):927-37. PMC: 4697261. DOI: 10.3109/08958378.2011.625995. View

4.
Liu Z, Maas K, Aune T . Comparison of differentially expressed genes in T lymphocytes between human autoimmune disease and murine models of autoimmune disease. Clin Immunol. 2004; 112(3):225-30. DOI: 10.1016/j.clim.2004.03.017. View

5.
Igarashi Y, Nakatsu N, Yamashita T, Ono A, Ohno Y, Urushidani T . Open TG-GATEs: a large-scale toxicogenomics database. Nucleic Acids Res. 2014; 43(Database issue):D921-7. PMC: 4384023. DOI: 10.1093/nar/gku955. View